Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ADH1B | P00325 | 2/20 | 0.36 |
| ▸ | ADH1C | P00326 | 2/20 | 0.36 |
| ▸ | ADH1A | P07327 | 2/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2647834 | 1.00 | ALDH1A1 (0.57) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL2650354 | 1.00 | ALDH1A1 (0.57) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL2650357 | 1.00 | ALDH1A1 (0.57) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL2647865 | 0.98 | ALDH1A1 (0.52) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL14519164 | 0.98 | ALDH1A1 (0.52) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL1001868 | 0.98 | ALDH1A1 (0.52) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL19993506 | 0.90 | ALDH1A1 (0.38) | ALDH1A1HSD17B10 | |
| SCHEMBL7739164 | 0.82 | SHBG (0.48) | ALDH1A1HSD17B10SHBGEPHX1CA12 | |
| SCHEMBL5412 | 0.82 | SHBG (0.48) | ALDH1A1HSD17B10SHBGEPHX1CA12 | |
| SCHEMBL21575869 | 0.82 | SHBG (0.48) | ALDH1A1HSD17B10SHBGEPHX1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108047058-A | N, N- dimethyl -4- cyclohexylamino cyclohexyl-methanes and its preparation method and application | 万华化学集团股份有限公司 | 2018-05-18 | — | — | CN | claimed |
| CN-108047058-A | N, N- dimethyl -4- cyclohexylamino cyclohexyl-methanes and its preparation method and application | 万华化学集团股份有限公司 | 2018-05-18 | — | — | CN | disclosed |
| CN-108047058-A | N, N- dimethyl -4- cyclohexylamino cyclohexyl-methanes and its preparation method and application | 万华化学集团股份有限公司 | 2018-05-18 | — | — | CN | disclosed |
| US-7582769-B2 | Dicycloalkyl urea glucokinase activators | NOVO NORDISK A/S (DK) | 2009-09-01 | — | — | US | disclosed |
| US-20090118501-A1 | Dicycloalkyl Urea Glucokinase Activators | NOVO NORDISK A/S (DK) | 2009-05-07 | — | — | US | disclosed |
| EP-1904466-A1 | DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS | Novo Nordisk A/S (DK) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007006760-A1 | DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS | NOVO NORDISK A/S (DK) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118501-A1 | Dicycloalkyl Urea Glucokinase Activators | GCK, GCKR, UCK2 | ALDH1A1 3782/4885HSD17B10 1699/4885ADH1B 2777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.